MICHAEL MIKITA: Open Payments
NPI 1902454804 · YPSILANTI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 26 payments from 9 companies in 2025. Trend: 2023 $504 · 2024 $238 · 2025 $536
Food & beverage: $468Education: $68
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $170 |
| Astellas Pharma US Inc | 2 | $89 |
| UROGEN PHARMA, INC. | 2 | $62 |
| Medtronic, Inc. | 2 | $51 |
| Janssen Biotech, Inc. | 3 | $48 |
| ABBVIE INC. | 2 | $45 |
| AVYXA PHARMA, LLC | 1 | $30 |
| ABC Home Medical Supply, Inc. | 1 | $21 |
| Olympus America Inc. | 1 | $19 |
Products named: GEMTESA, ORGOVYX, JELMYTO, ALTAVIVA, ERLEADA, LUPRON DEPOT, LUTRATE DEPOT, Xtandi.
Industry payments across MI — which companies pay providers there.
